A Double-Blind, Randomized, Placebo-Controlled, Multicenter, Crossover Study of MK-1029 in Adult Subjects With Persistent Asthma Who Remain Uncontrolled While Being Maintained on Montelukast
Phase of Trial: Phase II
Latest Information Update: 31 Jul 2014
At a glance
- Drugs MK 1029 (Primary)
- Indications Asthma
- Focus Therapeutic Use
- Sponsors Merck Sharp & Dohme
- 28 May 2014 Status changed from active, no longer recruiting to completed, as per ClinicalTrials.gov record.
- 28 Jan 2014 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 27 Aug 2013 Planned End Date changed from 1 Jan 2014 to 1 May 2014 as reported by ClinicalTrials.gov.